- Home
- EPM vs ACHV Comparison
EPM vs ACHV Comparison
Compare EPM & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EPM | ACHV |
|---|---|---|
| Founded | 2003 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 124.2M | 239.0M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | EPM | ACHV |
|---|---|---|
| Price | $3.59 | $4.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | $4.93 | ★ $15.50 |
| AVG Volume (30 Days) | 491.4K | ★ 494.9K |
| Earning Date | 02-10-2026 | 11-06-2025 |
| Dividend Yield | ★ 13.48% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $85,232,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.22 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.51 | $1.84 |
| 52 Week High | $5.70 | $5.78 |
Technical Indicators
Market Signals| Indicator | EPM | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 34.63 | 49.37 |
| Support Level | $3.54 | $4.25 |
| Resistance Level | $3.66 | $4.56 |
| Average True Range (ATR) | 0.11 | 0.20 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 13.10 | 35.43 |
Price Performance
Historical ComparisonAbout EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.